Introducing our NEW DRD Market Access Insights Report

MORSE Consulting Inc. is pleased to release our NEW Drugs for Rare Diseases (DRD) Market Access Trends & Insights Report. This comprehensive report offers an in-depth analysis of the unique challenges and opportunities in securing market access for drugs targeting rare diseases in Canada.

Our team of experts has utilized MORSE’s extensive experience and knowledge in the rare disease space to provide valuable insights and strategies for pharmaceutical companies navigating this complex market. The report includes:

  • Overview of the Canadian Rare Disease Policy & Pricing Landscape
    • National Rare Disease StrategyDRDs
    • Metrics to help determine net price potential
  • HTA Insights and Trends for DRDs
    • Analysis of CADTH and INESSS recommendations for DRDs
    • Challenges with negative recommendations & enablers of positive recommendations
    • Complex review process 
  • DRD-Specific Negotiation Trends and Challenges
    • Factors influencing pCPA mandates for DRDs
    • Strategies for addressing the unique challenges in DRD pricing and reimbursement
  • Innovative Agreements and Risk-Sharing Models for DRDs
    • Case studies on successful innovative agreements for DRDs
    • Best practices for designing and implementing risk-sharing models
  • Multi-Indication Negotiations
    • Preparing for multi-indication launches and negotiations
  • Best Practices for Stakeholder Engagement
  • Trends & Best practices in private payer space for DRDs

The 2024 DRD Market Access Trends & Insights Report is a must-have resource for pharmaceutical companies seeking to optimize their market access strategies for drugs targeting rare diseases in Canada. With our actionable insights and expert recommendations, you’ll be well-equipped to overcome the unique hurdles in the DRD market and ensure timely access to innovative treatments for rare disease patients.

  • Canadian Reimbursement Forecasting Timelines Report
  • Canadian Reimbursement Forecasting Timelines Report 1

For further information, please complete the form below.

This report is only available to pharmaceutical companies to assist with their reimbursement forecasting and planning.


We're committed to your privacy. MORSE may use the information you provide to us to contact you about our relevant content and services. Your name, address and all other personal information will not be sold or given to any other organization or list distributor. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

DRD Market Access Trends & Insights